ACoP 2025

Presenters: Joshua F. Apgar, Andrew Matteson

With hundreds of FDA and EMA submissions supported by QSP models, QSP has finally come of age. The now proven high return of investment from QSP has led to every major pharma company, and a significant number of biotechs investing in QSP groups or partnering with QSP vendors. However, the vast majority of preclinical and clinical programs are still not supported by QSP. At this point we see this not as a limitation of the value of QSP but as a challenge for implementing QSP at scale. This workshop will unveil Certara IQ, an innovative QSP environment that enables the scaling of QSP from only supporting a small minority of projects, to supporting the entire pipeline. We will focus on four key decision points in the drug development pipeline:

• New Target Feasibility
• Determining Best in Class Properties
• First In Human Dose Projection
• Recommended Phase 2 Dose

For each we will demonstrate how to use Certara IQ to efficiently answer these questions with worked practical examples.

講演者：: Amin Rostami-Hodjegan, PharmD, PhD (he/him/his)

Director of CAPKR ‘ CSO of Certara
The University of Manchester – Certara Inc
イギリス、シェフィールド

講演者：: Hannah M. Jones, PhD

開催場所: Willow Lake 3-5

講演者：: Matthew Zierhut

開催場所: Willow Lake 3-5

講演者：: Paul M. Diderichsen

開催場所: Willow Lake 3-5

講演者：: Sibylle Neuhoff

開催場所: Colorado B-D

講演者：: Doug Chung (panel)

開催場所: Willow Lake 3-5

Chair: Matt Zierhut

開催場所: Red Rock 8&9

Speaker/Panelist: Joshua F. Apgar, PhD

開催場所: Willow Lake 3-5

Speaker/Panelist: Kimiko McGirr

開催場所: Colorado B-D

Chair: Hunter Stephens

開催場所: Red Rock 8&9

講演者: Felix Stader

開催場所: Willow Lake 3-5

Presenters: Matthew L. Zierhut, PhD, MBA and Paul M. Diderichsen, PhD

開催場所: Red Rock 2

Attendees of this one-day workshop will learn about model-based meta-analysis (MBMA) – starting with the basic principles of meta-analysis and moving toward detailed applications of complex MBMA methodologies.   Concepts will be explained using case studies, accompanied by detailed hands-on R scripts and real datasets.  We will also explore datasets and perform directed analyses using Certara’s CODEX software platform.

• Some critical topics include:
• MBMA of binary and continuous data
• Dose-response MBMA
• Longitudinal MBMA
• Relative effect vs absolute outcome modeling
• Unstructured (nonparametric) placebo methodology
• Random effects and weighting of data
• Data transformations
• MBMA covariate exploration
• Joint MBMA of multiple endpoints

Authors: Bill Poland, Irene Bae

Sponsor: Merck & Co., Inc.

Authors: Shuang Xu, Bill Poland

Sponsor: Kartos

Authors: Leandro Pippa, Hunter Stephens, Stephen Duffull, Mirjam Trame

Sponsor: サターラ

Authors: Hunter Stephens, Mirjam Trame; Diane-Charlotte Imbs, Amandine Manon

Sponsor: サターラ

著者: Hunter Stephens

Sponsors: Certara, Novartis, Genentech

Authors: Shuang Xu, Bill Poland

Sponsor: Gilead

Authors: Carol Conchon Costa, Keith Nieforth, Mark Sale

Sponsor: サターラ

Authors: Ahmed Abulfathi, Sergio Iadevaia, Stephen Duffull

Sponsor: サターラ

Authors: Ahmed Abulfathi, Mirjam Trame

Sponsors: Certara, GMRI

Authors: Li Qin, Shuai Fu, Ahmed Abulfathi, Matt Zierhut

Sponsors: Certara, GSK

Authors: Todd Dumas, Shahram Mehr

Sponsors: Certara, ADMA Biologics

Authors: Bill Poland, Shuang Xu

Sponsor: Gilead Sciences

Authors: Swati Debroy, Shahram E. Mehr, Craig Comisar

Sponsor: Tourmaline Bio

著者: Dennis Reddyhoff

Authors: Yifan Yu, Mark Sale, Alex Mazur, James Craig, Keith Nieforth, Gustavo Doncel, Rachel Scott, Robert Bies

Sponsor: U Buffalo​

Authors: Xinnong Li, Alex Mazur, Mark Sale, Xinnong Li, Robert Bies, James Craig, Keith Nieforth, Robert Bies

Sponsor: U Buffalo​

Authors: Ana Carolina, Conchon Costa, Keith Nieforth, Natalia Valadares de Moraes, Mark Sale

Sponsor: U Florida​​

著者: Mark Sale ​

Sponsor: サターラ